Close
Nordic 9Nordic 9

+ND Capital (investor - Venture Capital)

United States nd.capital
See something wrong or missing? Let us know
Offices:San Jose

+ND Capital (f.k.a. NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.

Average round investment:36.18M USD
Average number per year:1.8
Distribution: 2025 (1)2024 (2)2023 (4)2021 (1)2020 (1)
Portfolio companies: Switzerland Haya TherapeuticsUnited Kingdom Constructive BioSwitzerland Vandria See the entire list
Mostly invests in: Switzerland Switzerland (5) Biotech (7)
See the entire list

Showing 3 of 9 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to +ND Capital

Name Criteria
United States Lux ​​Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Merieux Equity Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Luxembourg Alpha Intelligence Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Automotive, Transportation
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany Evonik Venture Capital GmbH
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
France Jolt Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Automotive, Transportation
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Northpond Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom abrdn
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Transportation
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Bioqube Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United Kingdom LifeArc Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United Kingdom Tapestry
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Automotive, Transportation
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top